C-reactive protein predicts early clinical outcomes and long-term mortality after left ventricular assisted device.

Hong-Tao TieRui ShiHenryk WelpSven MartensZhenhan LiJürgen SindermannSabrina Martens

Published in: The International journal of artificial organs (2022)

CRP is a reliable risk-stratification biomarker in patients receiving continuous-flow -LVAD and can be used as a predictor for short- and long-term outcomes.

Keyphrases

left ventricular
heart failure
hypertrophic cardiomyopathy
acute myocardial infarction
cardiac resynchronization therapy
mitral valve
aortic stenosis
left atrial
left ventricular assist device
coronary artery disease